These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 30315997

  • 1. Rocuronium Hypersensitivity: Does Off-Target Occupation of the MRGPRX2 Receptor Play a Role?
    Van Gasse AL, Elst J, Bridts CH, Mertens C, Faber M, Hagendorens MM, De Clerck LS, Sabato V, Ebo DG.
    J Allergy Clin Immunol Pract; 2019 Mar; 7(3):998-1003. PubMed ID: 30315997
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Immunoglobulin E cross-linking or MRGPRX2 activation: clinical insights from rocuronium hypersensitivity.
    Ebo DG, Van der Poorten ML, Elst J, Van Gasse AL, Mertens C, Bridts C, Garvey LH, Horiuchi T, Sabato V.
    Br J Anaesth; 2021 Jan; 126(1):e27-e29. PubMed ID: 33153719
    [No Abstract] [Full Text] [Related]

  • 4. Comparison of the passive mast cell activation test with the basophil activation test for diagnosis of perioperative rocuronium hypersensitivity.
    Elst J, Van Houdt M, van der Poorten MM, Van Gasse AL, Mertens C, Toscano A, Beyens M, De Boeck E, Sabato V, Ebo DG.
    Br J Anaesth; 2024 Mar; 132(3):483-490. PubMed ID: 37031026
    [Abstract] [Full Text] [Related]

  • 5. Predictive value of allergy tests for neuromuscular blocking agents: tackling an unmet need.
    Leysen J, Uyttebroek A, Sabato V, Bridts CH, De Clerck LS, Ebo DG.
    Clin Exp Allergy; 2014 Aug; 44(8):1069-75. PubMed ID: 24848972
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Reclassifying Anaphylaxis to Neuromuscular Blocking Agents Based on the Presumed Patho-Mechanism: IgE-Mediated, Pharmacological Adverse Reaction or "Innate Hypersensitivity"?
    Spoerl D, Nigolian H, Czarnetzki C, Harr T.
    Int J Mol Sci; 2017 Jun 07; 18(6):. PubMed ID: 28590439
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. MRGPRX2 and Adverse Drug Reactions.
    McNeil BD.
    Front Immunol; 2021 Jun 07; 12():676354. PubMed ID: 34421893
    [Abstract] [Full Text] [Related]

  • 12. Basophil and mast cell activation tests by flow cytometry in immediate drug hypersensitivity: Diagnosis and beyond.
    Elst J, Sabato V, van der Poorten MM, Van Gasse AL, Van Houdt M, Bridts CH, Walschot M, Timmermans JP, Pintelon I, Mertens C, Ebo DG.
    J Immunol Methods; 2021 Aug 07; 495():113050. PubMed ID: 33933471
    [Abstract] [Full Text] [Related]

  • 13. In Vitro Diagnosis of Immediate Drug Hypersensitivity Anno 2017: Potentials and Limitations.
    Decuyper II, Mangodt EA, Van Gasse AL, Claesen K, Uyttebroek A, Faber M, Sabato V, Bridts CH, Mertens C, Hagendorens MM, De Clerck LS, Ebo DG.
    Drugs R D; 2017 Jun 07; 17(2):265-278. PubMed ID: 28258478
    [Abstract] [Full Text] [Related]

  • 14. Mas-Related G Protein-Coupled Receptor-X2 (MRGPRX2) in Drug Hypersensitivity Reactions.
    Porebski G, Kwiecien K, Pawica M, Kwitniewski M.
    Front Immunol; 2018 Jun 07; 9():3027. PubMed ID: 30619367
    [Abstract] [Full Text] [Related]

  • 15. Recent Knowledge and Insights on the Mechanisms of Immediate Hypersensitivity and Anaphylaxis: IgE/FcεRI- and Non-IgE/FcεRI-Dependent Anaphylaxis.
    Ebo DG, Beyens M, Heremans K, van der Poorten MM, Van Gasse AL, Mertens C, Houdt MV, Sabato V, Elst J.
    Curr Pharm Des; 2023 Jun 07; 29(3):178-184. PubMed ID: 36284380
    [Abstract] [Full Text] [Related]

  • 16. In Vitro Diagnosis of Immediate Drug Hypersensitivity During Anesthesia: A Review of the Literature.
    Ebo DG, Faber M, Elst J, Van Gasse AL, Bridts CH, Mertens C, De Clerck LS, Hagendorens MM, Sabato V.
    J Allergy Clin Immunol Pract; 2018 Jun 07; 6(4):1176-1184. PubMed ID: 29454709
    [Abstract] [Full Text] [Related]

  • 17. Differentiating the cellular and humoral components of neuromuscular blocking agent-induced anaphylactic reactions in patients undergoing anaesthesia.
    Aalberse RC, Kleine Budde I, Mulder M, Stapel SO, Paulij W, Leynadier F, Hollmann MW.
    Br J Anaesth; 2011 May 07; 106(5):665-74. PubMed ID: 21414980
    [Abstract] [Full Text] [Related]

  • 18. Mas-related G protein-coupled receptor MRGPRX2 in human basophils: Expression and functional studies.
    Toscano A, Elst J, Van Gasse AL, Beyens M, van der Poorten ML, Bridts CH, Mertens C, Van Houdt M, Hagendorens MM, Van Remoortel S, Timmermans JP, Ebo DG, Sabato V.
    Front Immunol; 2022 May 07; 13():1026304. PubMed ID: 36726977
    [Abstract] [Full Text] [Related]

  • 19. Flow-based allergen testing: Can mast cells beat basophils?
    Ebo DG, Heremans K, Beyens M, van der Poorten MM, Van Gasse AL, Mertens C, Van Houdt M, Sabato V, Elst J.
    Clin Chim Acta; 2022 Jul 01; 532():64-71. PubMed ID: 35609709
    [Abstract] [Full Text] [Related]

  • 20. MRGPRX2-mediated mast cell response to drugs used in perioperative procedures and anaesthesia.
    Navinés-Ferrer A, Serrano-Candelas E, Lafuente A, Muñoz-Cano R, Martín M, Gastaminza G.
    Sci Rep; 2018 Aug 02; 8(1):11628. PubMed ID: 30072729
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.